Cite
HARVARD Citation
Banerji, D. et al. (2016). Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations. Respiratory medicine. pp. 79-80. [Online].